NCT02983253View on ClinicalTrials.gov

Immunmodulation in Patients With HHT

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Hereditary Haemorrhagic Telangiectasia (HHT)
Interventions
OTHER

blood sample

none, only laboratory tests on blood serum

Trial Locations (1)

45147

University Hospital Essen, Essen

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT02983253 - Immunmodulation in Patients With HHT | Biotech Hunter | Biotech Hunter